v3.26.1
Shareholders' Equity - Restricted Stock (Details) - Restricted Stock Unit (RSU) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Stock based compensation expense $ 547,527 $ 385,838    
Compensation cost not yet recognized $ 3,598,699   $ 4,146,227  
Weighted average period for recognition 1 year 3 months 10 days   1 year 4 months 13 days  
Number outstanding        
Balance non-vested Stock at beginning of period (in shares) 781,792 560,970 560,970  
Granted (in shares) 0   488,283  
Vested (in shares) 0   (267,461)  
Balance non-vested Stock at end of period (in shares) 781,792   781,792 560,970
Weighted Average Remaining Life        
Balance non-vested Stock at end of period (in years) 1 year 5 months 15 days   1 year 8 months 15 days 1 year 7 months 9 days
Granted (in years)     1 year 6 months  
Weighted Average Grant Date Fair Value        
Weighted Average Grant Date Fair Value , beginning of period $ 5.06 $ 5.77 $ 5.77  
Weighted Average Grant Date Fair Value, Granted 0   4.78  
Weighted Average Grant Date Fair Value, Vested 0   5.6  
Weighted Average Grant Date Fair Value, end of period $ 5.06   $ 5.06 $ 5.77
Board of Directors        
Number outstanding        
Granted (in shares) 0      
Management, Employees, and Board Of Directors        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Vesting period 3 years      
Number outstanding        
Granted (in shares)     488,283  
Weighted Average Grant Date Fair Value        
Weighted Average Grant Date Fair Value, Granted     $ 4.78